Lexapro (Escitalopram) Tapering with Mark Leeds, D.O.
Escitalopram, sold under the brand name Lexapro, is one of the most widely prescribed SSRIs (selective serotonin reuptake inhibitors) in the United States. Millions of patients take Lexapro for depression, generalized anxiety disorder, and other conditions. While this medication helps many people, a significant number of patients eventually want to stop taking it — and discover that doing so is far more difficult than they were led to believe.
Dr. Leeds provides expert Lexapro tapering services through a concierge telemedicine practice serving patients throughout the state of Florida. This is not addiction treatment. This is psychiatric medication deprescribing — the careful, medically supervised process of helping patients safely discontinue a medication their body has become physically dependent on.
Physical Dependence Is Not Addiction
One of the most important things for patients to understand is that physical dependence on Lexapro is not addiction. Patients who were prescribed escitalopram by their doctors and took it exactly as directed are not addicts. They have a physiological dependence on a prescribed medication — a dependence that developed as a predictable consequence of long-term use.
For years, patients were told that SSRIs are “not addictive.” While this is technically true in the behavioral sense — escitalopram does not produce euphoria, drug-seeking behavior, or the compulsive use patterns associated with addiction — it is deeply misleading. SSRIs absolutely produce physical dependence, and discontinuation can trigger withdrawal syndromes that range from uncomfortable to debilitating.
The conventional medical term is antidepressant discontinuation syndrome, but many patients experience symptoms far beyond what this mild-sounding label implies. Some individuals develop protracted neurological effects that persist for months or longer, including symptoms similar to what is now being recognized as BIND (benzodiazepine-induced neurological dysfunction). The medical establishment has been slow to acknowledge the severity of these withdrawal syndromes, leaving countless patients without adequate support.
Why Lexapro Is Difficult to Stop
Escitalopram works by blocking the reuptake of serotonin in the brain, increasing the availability of this neurotransmitter at synaptic junctions. Over time, the brain adapts to this altered neurochemical environment. Receptors downregulate, signaling pathways adjust, and the entire serotonergic system recalibrates around the presence of the medication.
When the drug is reduced too quickly or stopped abruptly, the brain’s adapted state is suddenly disrupted. The result is a constellation of withdrawal symptoms that can be both physically and emotionally overwhelming. Common Lexapro withdrawal symptoms include:
- Brain zaps — electric shock-like sensations in the head, one of the hallmark symptoms of SSRI withdrawal
- Dizziness and vertigo — often severe enough to interfere with daily activities
- Emotional flooding — intense waves of anxiety, sadness, irritability, or emotional instability that patients may mistake for a return of their original condition
- Insomnia and sleep disturbances — difficulty falling asleep, staying asleep, or experiencing restorative sleep
- Gastrointestinal disturbances — nausea, diarrhea, cramping, and appetite changes
- Flu-like symptoms — fatigue, body aches, chills, and general malaise
- Sensory disturbances — tingling, numbness, heightened sensitivity to light and sound
- Cognitive difficulties — brain fog, difficulty concentrating, and memory issues
Many patients and even some prescribers confuse these withdrawal symptoms with a relapse of the original psychiatric condition, leading to the mistaken conclusion that the patient “needs” the medication indefinitely. Dr. Leeds understands the critical difference between withdrawal symptoms and relapse, and tailors the tapering process accordingly.
The Problem with Conventional Tapering
Psychiatry has historically been closed-minded about recognizing the harm caused by overprescribing. Many patients were prescribed SSRIs like Lexapro unnecessarily, kept on them for far too long, or given no exit plan whatsoever. When patients do express a desire to stop, conventional approaches often involve rapid tapers — cutting the dose in half every few weeks, for example — that are far too aggressive for many individuals.
The standard approach fails because it ignores a fundamental pharmacological principle: the relationship between dose and receptor occupancy is not linear. It is hyperbolic. This means that reducing from 20 mg to 10 mg has a relatively modest effect on serotonin transporter occupancy, but reducing from 5 mg to 0 mg has an enormous effect. The final milligrams matter the most, and that is exactly where conventional tapers are most reckless.
Hyperbolic Tapering and the Maudsley Approach
Dr. Leeds follows an evidence-based approach grounded in the principles described in the Maudsley Deprescribing Guidelines, one of the most important references in the field of psychiatric medication tapering. The Maudsley guidelines emphasize hyperbolic tapering — a method in which dose reductions become progressively smaller as the total dose decreases.
In practical terms, this means that a patient tapering from 20 mg of Lexapro might reduce by 5 mg in early stages, but by the time they reach lower doses, reductions may be fractions of a milligram at a time. This approach respects the hyperbolic dose-receptor occupancy curve and minimizes the neurological disruption that triggers withdrawal symptoms.
To achieve the precise doses required in the later stages of tapering, Dr. Leeds works with compound pharmacies that prepare custom liquid formulations of escitalopram. Standard tablet sizes simply cannot provide the granular dosing needed for safe hyperbolic tapering. Liquid formulations allow for exact measurements — sometimes as small as fractions of a milligram — giving patients and their physician complete control over the pace of the taper.
What to Expect During the Tapering Process
The timeline for safely tapering off Lexapro varies considerably from patient to patient. Factors such as the duration of use, the current dose, individual neurochemistry, and previous tapering attempts all play a role. For many patients, the process takes months to well over a year. Dr. Leeds emphasizes that there is no reason to rush — the goal is to get patients off the medication safely and comfortably, not to meet an arbitrary deadline.
Throughout the process, Dr. Leeds uses adjunct treatments and individualized pacing to manage symptoms and support the patient’s overall well-being. Each patient’s taper schedule is customized, with the flexibility to pause, slow down, or adjust based on how they are responding. This is the opposite of a one-size-fits-all protocol.
Why Choose Dr. Leeds for Lexapro Tapering
Dr. Mark Leeds brings a unique combination of expertise and commitment to patients seeking help with Lexapro discontinuation. Key practice differentiators include:
- Board of Integrative and Concierge Medicine (BIC) — Dr. Leeds serves on the BIC board, reflecting a commitment to individualized, patient-centered care
- The Rehab Podcast — Dr. Leeds hosts a podcast focused on evidence-based approaches to medication management and recovery, providing education to patients and practitioners
- Weekly hour-long appointments — unlike conventional psychiatric visits that last 15 minutes, Dr. Leeds provides extended appointments to thoroughly monitor progress and adjust the tapering plan
- 24/7 text access — patients can reach Dr. Leeds directly via text at any time, ensuring support is available when withdrawal symptoms or concerns arise between appointments
- Direct physician care — patients work directly with Dr. Leeds throughout the entire tapering process, not with rotating staff or mid-level providers
- Concierge telemedicine throughout Florida — the practice operates via telemedicine, making expert tapering care accessible to patients anywhere in the state without the need to travel to an office
Taking the First Step
If you or someone you know has been taking Lexapro and wants to explore tapering options, Dr. Leeds is here to help. Whether a patient has tried to stop before and struggled with withdrawal, or is just beginning to consider discontinuation, the first step is a thorough evaluation to develop a safe, individualized plan.
Contact Dr. Leeds today to schedule a consultation and learn more about safe, evidence-based Lexapro tapering.
